|
FBXO45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.701700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.051400E-01 |
| Normal-vs-Stage2 |
4.711800E-01 |
| Normal-vs-Stage3 |
1.548370E-01 |
| Normal-vs-Stage4 |
6.700300E-02 |
| Stage1-vs-Stage2 |
7.061000E-01 |
| Stage1-vs-Stage3 |
3.914600E-01 |
| Stage1-vs-Stage4 |
4.644200E-02 |
| Stage2-vs-Stage3 |
7.460400E-01 |
| Stage2-vs-Stage4 |
1.600010E-01 |
| Stage3-vs-Stage4 |
1.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.122790E-01 |
| Normal-vs-AfricanAmerican |
3.350800E-01 |
| Normal-vs-Asian |
7.171500E-02 |
| Caucasian-vs-AfricanAmerican |
7.929000E-01 |
| Caucasian-vs-Asian |
6.249200E-01 |
| AfricanAmerican-vs-Asian |
4.991600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.777200E-01 |
| Normal-vs-Female |
2.198100E-03 |
| Male-vs-Female |
5.223500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.634200E-01 |
| Normal-vs-Extreme_Weight |
9.085200E-01 |
| Normal-vs-Obese |
1.007960E-01 |
| Normal-vs-Extreme_Obese |
6.313200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.221000E-01 |
| Normal_Weight-vs-Obese |
4.887800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.361800E-01 |
| Extreme_Weight-vs-Obese |
1.506600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.946000E-01 |
| Obese-vs-Extreme_Obese |
8.588400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.524200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.796500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.549400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.062650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.346980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.060700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.707700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.955600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.097050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.597360E-01 |
| Normal-VS-Type2 PRCC |
7.799200E-01 |
| Normal-VS-KIRP CIMP |
1.678320E-03 |
| Normal-VS-Unclassified PRCC |
2.887600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.322220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.26849999999513E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.067400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.64330000000224E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.029200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.092020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.753400E-01 |
| Normal-vs-N1 |
2.019900E-03 |
| Normal-vs-N2 |
4.512000E-01 |
| N0-vs-N1 |
1.817330E-04 |
| N0-vs-N2 |
3.951200E-01 |
| N1-vs-N2 |
8.829400E-01 |
|
|
